AVXL has been in the news 306% more than usual
Sep 19, 2024, 2:32 PM
-0.53%
What does AVXL do
Anavex Life Sciences, a New York-based biopharmaceutical company, develops therapeutics for neurodegenerative diseases and employs 40 staff. Its lead compound, ANAVEX 2-73, targets Alzheimer's and Parkinson's diseases.
AVXL has been in the news recently: Apollo Intelligence has appointed Tal Rosenberg as CEO to drive growth and innovation for its clients in the life sciences sector. Additionally, Komodo Health has launched new tools, MapAI™ and MapExplorer™, to improve patient insights and decision-making for healthcare organizations.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.